|
|
Previous Article | Table of Contents | Next Article 
Characterization of functionally distinct subpopulations of CD34+ cord
blood cells in serum-free long-term cultures supplemented with
hematopoietic cytokines
H Mayani, W Dragowska and PM Lansdorp
Division of Hematology, Terry Fox Laboratory, British Columbia Cancer
Agency, Vancouver, Canada.
We have previously identified, based on the expression of the CD45RA and
CD71 antigens, three major subpopulations of CD34+ cells derived from human
umbilical cord blood: CD34+ CD45RAloCD71lo cells (up to 42% multipotent
progenitors), CD34+ CD45RA+ CD71lo cells (90% myeloid progenitors), and
CD34+ CD45RAloCD71+ cells (70% erythroid progenitors). In the present
study, we have investigated the long-term proliferation and differentiation
of these subpopulations in response to hematopoietic cytokines. Cells from
each subpopulation were cultured for 38 days in serum- and stroma-free
liquid cultures supplemented with cytokine combinations that favor either
erythropoiesis or myelopoiesis. In keeping with their high content of
primitive progenitors, CD34+ CD45RAloCD71lo cells showed the highest CD34+
cell expansion (up to 532- fold) throughout the culture period, followed by
CD34+ CD45RA+ CD71lo (130-fold) and CD34+ CD45RAloCD71+ (28-fold) cells.
Interestingly, the cytokine combination favoring myelopoiesis was always
more efficient in inducing CD34+ cell expansion than the one favoring
erythropoiesis. In all but one of the cultures, a predominance of
myelopoiesis was observed after 2 weeks, even in those supplemented with
the cytokine mixture that favors erythropoiesis. Only when CD34+
CD45RAloCD71+ cells were cultured in the presence of erythroid cytokine
mixture, erythropoiesis was evident at all time points. However, such
cultures could be sustained for only 29 days. The results of this study
demonstrate that the cord blood-derived CD34+ cell compartment consists of
functionally distinct cell subpopulations that possess different
proliferative capacities in vitro. Our results also show that the cytokine
combinations used here were able to modulate proliferation and, to a much
lesser extent, differentiation of such subpopulations, probably by favoring
the expansion of committed progenitors rather than by acting on uncommitted
cells.
Volume 82,
Issue 9,
pp. 2664-2672,
11/01/1993
Copyright © 1993 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. E. Daldrup-Link, M. Rudelius, G. Piontek, S. Metz, R. Brauer, G. Debus, C. Corot, J. Schlegel, T. M. Link, C. Peschel, et al.
Migration of Iron Oxide-labeled Human Hematopoietic Progenitor Cells in a Mouse Model: In Vivo Monitoring with 1.5-T MR Imaging Equipment
Radiology,
January 1, 2005;
234(1):
197 - 205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chalandon, X. Jiang, G. Hazlewood, S. Loutet, E. Conneally, A. Eaves, and C. Eaves
Modulation of p210BCR-ABL activity in transduced primary human hematopoietic cells controls lineage programming
Blood,
May 1, 2002;
99(9):
3197 - 3204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. de Wynter, C. M. Heyworth, N. Mukaida, E. Jaworska, A. Weffort-Santos, K. Matushima, and N. G. Testa
CCR1 chemokine receptor expression isolates erythroid from granulocyte-macrophage progenitors
J. Leukoc. Biol.,
September 1, 2001;
70(3):
455 - 460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Rosler, J. E. Brandt, J. Chute, and R. Hoffman
An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells
Blood,
November 15, 2000;
96(10):
3414 - 3421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J.G. Southcott, M. J.A. Tanner, and D. J. Anstee
The Expression of Human Blood Group Antigens During Erythropoiesis in a Cell Culture System
Blood,
June 15, 1999;
93(12):
4425 - 4435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. de Wynter, D. Buck, C. Hart, R. Heywood, L.H. Coutinho, A. Clayton, J.A. Rafferty, D. Burt, G. Guenechea, J. A. Bueren, et al.
CD34+AC133+ Cells Isolated from Cord Blood are Highly Enriched in Long-Term Culture-Initiating Cells, NOD/SCID-Repopulating Cells and Dendritic Cell Progenitors
Stem Cells,
November 1, 1998;
16(6):
387 - 396.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Mohle, F. Bautz, S. Rafii, M. A.S. Moore, W. Brugger, and L. Kanz
The Chemokine Receptor CXCR-4 Is Expressed on CD34+ Hematopoietic Progenitors and Leukemic Cells and Mediates Transendothelial Migration Induced by Stromal Cell-Derived Factor-1
Blood,
June 15, 1998;
91(12):
4523 - 4530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mayani and P. M. Lansdorp
Biology of Human Umbilical Cord Blood-Derived Hematopoietic Stem/Progenitor Cells
Stem Cells,
May 1, 1998;
16(3):
153 - 165.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Sanz, A. Benito, M. Silva, B. Albella, C. Richard, J. C. Segovia, A. Insunza, J. A. Bueren, and J. L. Fernandez-Luna
The Expression of Bcl-x Is Downregulated During Differentiation of Human Hematopoietic Progenitor Cells Along the Granulocyte But Not the Monocyte/Macrophage Lineage
Blood,
May 1, 1997;
89(9):
3199 - 3204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Piacibello, F. Sanavio, L. Garetto, A. Severino, D. Bergandi, J. Ferrario, F. Fagioli, M. Berger, and M. Aglietta
Extensive Amplification and Self-Renewal of Human Primitive Hematopoietic Stem Cells From Cord Blood
Blood,
April 15, 1997;
89(8):
2644 - 2653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Takakura, H. Kodama, S. Nishikawa, and S.-I. Nishikawa
Preferential Proliferation of Murine Colony-forming Units in Culture in a Chemically Defined Condition with a Macrophage Colony-stimulating Factor-negative Stromal Cell Clone
J. Exp. Med.,
December 15, 1996;
184(6):
2301 - 2310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. de Wynter, G Nadali, L. Coutinho, and N. Testa
Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets
Stem Cells,
September 1, 1996;
14(5):
566 - 576.
[Abstract]
|
 |
|
|
|